Logo for OPKO Health Inc

OPKO Health Investor Relations Material

Latest events

Logo for OPKO Health Inc

Q4 2023

OPKO Health
Logo for OPKO Health

Q4 2023

27 Feb, 2024
Logo for OPKO Health

Q3 2023

6 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from OPKO Health Inc

Access all reports
Segment Data
Access more data
Revenue by
Business area
Diagnostics
Pharmaceutical
Expenses by
Financials
OPKO Health, Inc., together with its subsidiaries, provides diagnostic and pharmaceutical products to patients in the United States and internationally. The company offers clinical laboratory diagnostic services under the Diagnostic Systems Laboratories (DSL) brand name. It also develops and commercializes pharmaceutical products for oncology, cardiovascular disease, hospital intensive care, gout and metabolic disorders, reproductive health and urology; as well as complementary dietary supplement products for women’s health, eye care and mineral deficiencies. In addition, it engages in the research and development of proprietary medical imaging contrast agents for use in cardiac electrophysiological procedures; along with advanced personalized genetic diagnostics technology using microfluidics extracted from blood samples to help identify genetic markers associated with disease onset or progression; as well as biomarkers associated with efficacy that are useful in assessing treatment options